Skip to main content

Advertisement

ADVERTISEMENT

Volume 18 - Issue 12 - December, 2006

Feature

Clinical Images
08/01/2008
Ravi K. Garg, MD and Neeraj Jolly, MD
Ravi K. Garg, MD and Neeraj Jolly, MD...
Case Presentation. A 65-year-old female with squamous cell carcinoma of the uterus was admitted with acute dyspnea and hypotension. A computed tomography (CT) angiogram using the pulmonaryembolism (PE) protocol revealed evidence of multiple...
Case Presentation. A 65-year-old female with squamous cell carcinoma of the uterus was admitted with acute dyspnea and hypotension. A computed tomography (CT) angiogram using the pulmonaryembolism (PE) protocol revealed evidence of multiple...
Case Presentation. A 65-year-old...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Brian Cabarrus, MD, Nazim U. Khan, MD, Rony L. Shammas, MD
Brian Cabarrus, MD, Nazim U. Khan, MD...
Coronary fistulae are congenital or acquired communications between a coronary artery and either a chamber of the heart (coronary-cameral fistula) or any segment of the systemic or pulmonary circulation bypassing the myocardial capillary...
Coronary fistulae are congenital or acquired communications between a coronary artery and either a chamber of the heart (coronary-cameral fistula) or any segment of the systemic or pulmonary circulation bypassing the myocardial capillary...
Coronary fistulae are congenital...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Toby Ferguson, MD, Lauren H. Sansing, MD, Howard Herrmann, MD, Brett Cucchiara, MD
Toby Ferguson, MD, Lauren H. Sansing,...
The precise role of patent foramen ovale (PFO) in causing stroke remains controversial. Clinical factors felt to support a diagnosis of paradoxical embolization through a PFO include presence of concurrent deep vein thrombosis (DVT) and onset...
The precise role of patent foramen ovale (PFO) in causing stroke remains controversial. Clinical factors felt to support a diagnosis of paradoxical embolization through a PFO include presence of concurrent deep vein thrombosis (DVT) and onset...
The precise role of patent...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Carlos Fernandez-Pereira, MD, Gaston Rodriguez-Granillo, MD, Alfredo E. Rodriguez, MD, PhD
Carlos Fernandez-Pereira, MD, Gaston ...
Since the introduction of drug-eluting stents (DES) during interventional procedures, several randomized studies have demonstrated a significant reduction in coronary restenosis and target vessel revascularizations.1–4 However, despite the...
Since the introduction of drug-eluting stents (DES) during interventional procedures, several randomized studies have demonstrated a significant reduction in coronary restenosis and target vessel revascularizations.1–4 However, despite the...
Since the introduction of...
08/01/2008
Journal of Invasive Cardiology

Department

Letters to the Editor
08/01/2008
Jack P. Chen, MD
Jack P. Chen, MD
To the Editor: Today’s vast armamentarium of percutaneous coronary interventional devices has both simplified and complicated the procedure. While user-friendly catheters, wires and stents have allowed the seasoned interventionalist to...
To the Editor: Today’s vast armamentarium of percutaneous coronary interventional devices has both simplified and complicated the procedure. While user-friendly catheters, wires and stents have allowed the seasoned interventionalist to...
To the Editor: Today’s vast...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Kul Aggarwal, MD and Lokesh Tejwani, MD
Kul Aggarwal, MD and Lokesh Tejwani, ...
The number of patients receiving pacemaker and implantable cardioverter-defibrillator (ICD) implants is rapidly increasing. The number of permanent pacemaker implants in the United States increased from about 95,000 in 1990 to 250,000 in...
The number of patients receiving pacemaker and implantable cardioverter-defibrillator (ICD) implants is rapidly increasing. The number of permanent pacemaker implants in the United States increased from about 95,000 in 1990 to 250,000 in...
The number of patients receiving...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Robert J. Applegate, MD, Mark A. Grabarczyk, MD, David C. Sane, MD, Matthew T. Sacrinty, MPH, Jason E. Goodin, BA, G. Sidney Statonk, MD, Talal T. Baki, MD, Sanjay K. Gandhi, MD, Michael A. Kutcher, MD, William C. Little, MD
Robert J. Applegate, MD, Mark A. Grab...
Several clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition reduces the ischemic complications of percutaneous coronary interventions (PCI).1–4 Comparative data between agents, however, are very...
Several clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition reduces the ischemic complications of percutaneous coronary interventions (PCI).1–4 Comparative data between agents, however, are very...
Several clinical trials have...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Clemens Steinwender, MD, Christian Gabriel, MD, Franz Leisch, MD
Clemens Steinwender, MD, Christian G...
There is increasing evidence that the liberation of stem cells by use of granulocyte-colony stimulating factor (G-CSF) with or without their transcoronary transplantation is feasible and can improve cardiac function in humans after acute...
There is increasing evidence that the liberation of stem cells by use of granulocyte-colony stimulating factor (G-CSF) with or without their transcoronary transplantation is feasible and can improve cardiac function in humans after acute...
There is increasing evidence...
08/01/2008
Journal of Invasive Cardiology
Continuing Education
08/01/2008
*Marc Cohen, MD, Jose Diez, MD, Edward Fry, MD, Sunil V. Rao, MD, James J. Ferguson III, MD, James Zidar, MD, Glenn Levine, MD, Jacob Shani, MD
*Marc Cohen, MD, Jose Diez, MD, Edwar...
Target Audience: Clinical Cardiologists, Interventional Cardiologists and Nurses. Release Date: 12-01-06 Expiration Date: 11-30-07 Learning Objectives: Upon completion of this educational activity, participants should be able to: Educate...
Target Audience: Clinical Cardiologists, Interventional Cardiologists and Nurses. Release Date: 12-01-06 Expiration Date: 11-30-07 Learning Objectives: Upon completion of this educational activity, participants should be able to: Educate...
Target Audience: Clinical...
08/01/2008
Journal of Invasive Cardiology
Continuing Education
08/01/2008
*Marc Cohen, MD, Jose Diez, MD, Edward Fry, MD, Sunil V. Rao, MD, James J. Ferguson III, MD, James Zidar, MD, Glenn Levine, MD, Jacob Shani, MD
*Marc Cohen, MD, Jose Diez, MD, Edwar...
(PART II) A second group of patients who have received less attention were those who were switched at randomization; approximately three quarters of the patients were on some form of antithrombotic therapy prior to randomization — half of...
(PART II) A second group of patients who have received less attention were those who were switched at randomization; approximately three quarters of the patients were on some form of antithrombotic therapy prior to randomization — half of...
(PART II) A second group of...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement